Scarica l'app Stockscreener
6.19
1.81%
0.11
Dopo l'orario di chiusura:
6.22
0.03
+0.48%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLDB Giù?
Forum
Previsione
Frazionamento azionario
Solid Biosciences Inc Borsa (SLDB) Ultime notizie
What analysts say about Solid Biosciences Inc. stockQuarterly Investment Review & Growth-Oriented Investment Plans - mfd.ru
Solid Biosciences (SLDB) Gets a Buy from Wedbush - The Globe and Mail
Citizens reiterates Market Outperform rating on Solid Biosciences stock By Investing.com - Investing.com Nigeria
Citizens reiterates Market Outperform rating on Solid Biosciences stock - Investing.com
Solid Biosciences advances Duchenne treatment with FDA alignment By Investing.com - Investing.com South Africa
Solid Biosciences: Positive FDA Meeting SGT-003 Sets Up Next Milestones (NASDAQ:SLDB) - Seeking Alpha
Needham Reiterates Buy Rating for Solid Biosciences (SLDB) at $1 - GuruFocus
Needham & Company LLC Reaffirms Buy Rating for Solid Biosciences (NASDAQ:SLDB) - MarketBeat
Solid Biosciences (SLDB) Gains FDA Alignment for Duchenne Trial - GuruFocus
Solid Biosciences Receives Positive FDA Feedback - Intellectia AI
Solid Biosciences To Dose First Patient In IMPACT DUCHENNE Phase 3 Trial In Q1'26 - Nasdaq
Solid Biosciences stock rises after FDA alignment on Phase 3 trial design - Investing.com Australia
Solid Biosciences (SLDB) Advances Duchenne Therapy with FDA Support - GuruFocus
Solid Biosciences Aligns With FDA on Phase 3 Trial Design for Duchenne Muscular Dystrophy Gene Therapy - marketscreener.com
Solid Bio, FDA agree on trial for Duchenne drug (SLDB:NASDAQ) - Seeking Alpha
Solid Biosciences advances Duchenne treatment with FDA alignment - Investing.com
Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy - The Manila Times
Merger Talk: Why is Solid Biosciences Inc. stock going upWeekly Stock Analysis & Safe Entry Point Identification - baoquankhu1.vn
Death Cross: What are Solid Biosciences Incs earnings expectations2025 Trade Ideas & Fast Entry Momentum Alerts - baoquankhu1.vn
Solid Biosciences CTO Herzich sells $70k in SLDB stock By Investing.com - Investing.com Canada
Solid Biosciences chief regulatory officer sells $79,544 in SLDB By Investing.com - Investing.com UK
Solid Biosciences CMO Brooks sells $81k in shares By Investing.com - Investing.com South Africa
Solid Biosciences chief regulatory officer sells $79,544 in SLDB - Investing.com India
Solid Biosciences CTO Herzich sells $70k in SLDB stock - Investing.com
Solid Biosciences CEO Cumbo sells $315,092 in stock By Investing.com - Investing.com Canada
Ilan Ganot, Solid Biosciences director, sells $46k in shares By Investing.com - Investing.com UK
Solid Biosciences CEO Cumbo sells $315,092 in stock - Investing.com Nigeria
Ilan Ganot, Solid Biosciences director, sells $46k in shares - Investing.com
Solid Biosciences (NASDAQ:SLDB) CFO Kevin Tan Sells 14,783 Shares - MarketBeat
Solid Biosciences (NASDAQ:SLDB) CTO Sells $70,228.20 in Stock - MarketBeat
Solid Biosciences Flies Ahead of Summit - Baystreet.ca
Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Insider Selling: Solid Biosciences (NASDAQ:SLDB) Insider Sells 12,616 Shares of Stock - MarketBeat
Solid Biosciences Inc. (NASDAQ:SLDB) Sees Large Decline in Short Interest - MarketBeat
Solid Biosciences CFO sells $172k in shares By Investing.com - Investing.com UK
Solid Biosciences (NASDAQ:SLDB) CFO Kevin Tan Sells 26,837 Shares - MarketBeat
Alexander Cumbo Sells 80,258 Shares of Solid Biosciences (NASDAQ:SLDB) Stock - MarketBeat
Gabriel Brooks Sells 28,335 Shares of Solid Biosciences (NASDAQ:SLDB) Stock - MarketBeat
Solid Biosciences (NASDAQ:SLDB) COO Sells $243,245.24 in Stock - MarketBeat
Solid Biosciences COO Howton sells $243k in shares By Investing.com - Investing.com Australia
Paul Herzich Sells 26,250 Shares of Solid Biosciences (NASDAQ:SLDB) Stock - MarketBeat
Solid Biosciences CFO sells $172k in shares - Investing.com
Solid Biosciences COO Howton sells $243k in shares - Investing.com
Insider Selling: Solid Biosciences (NASDAQ:SLDB) Insider Sells 26,535 Shares of Stock - MarketBeat
Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):